Eficacia de la tromboprofilaxis con heparina de bajo peso molecular en pacientes críticos con COVID-19: estudio observacional, prospectivo y multicéntrico
Open Access
- 22 March 2022
- journal article
- research article
- Published by Elsevier in Revista Española de Anestesiología y Reanimación
- Vol. 70 (3) , 129-139
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- ISTH interim guidance on recognition and management of coagulopathy in COVID‐19: A commentJournal of Thrombosis and Haemostasis, 2022
- The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): Report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States citiesCardiovascular Pathology, 2020
- Autopsy Findings and Venous Thromboembolism in Patients With COVID-19Annals of Internal Medicine, 2020
- Neutrophil extracellular traps in COVID-19JCI Insight, 2020
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-UpJACC, 2020
- High incidence of venous thromboembolic events in anticoagulated severe COVID‐19 patientsJournal of Thrombosis and Haemostasis, 2020
- High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort studyIntensive Care Medicine, 2020
- Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?Thrombosis and Haemostasis, 2020
- A lung rescue team improves survival in obesity with acute respiratory distress syndromeCritical Care, 2020
- More than an anticoagulant: Do heparins have direct anti-inflammatory effects?Thrombosis and Haemostasis, 2017